Illumina Inc

Illumina Inc

ILMN

Market Cap$12B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Illumina IncIllumina Inc-9.9--45%30.9

Earnings Call Q4 2024

February 6, 2025 - AI Summary

Q4 2024 Financial Performance: Illumina reported Q4 revenue of $1.1 billion, reflecting a year-over-year growth of approximately 1%. The growth was primarily driven by a 2% increase in sequencing consumables revenue, attributed to the successful transition to the NovaSeq X series, which averaged a pull-through of $1.3 million per system. The company's revenue exceeded expectations due to high NovaSeq X shipments, with 91 instruments placed in the quarter, bringing the installed base to 630.
2025 Revenue Guidance: For the full year 2025, Illumina expects revenue growth in the low single-digit percentage range on a constant currency basis, with a normalized operating margin of approximately 23% (an improvement of 170 basis points from 2024) and a diluted EPS in the range of $4.50 to $4.65. This guidance does not account for potential disruptions resulting from recent Chinese governmental actions.
Challenges in China: China represents approximately 7% of Illumina’s global revenue. Despite recent governmental scrutiny, CEO Jacob Thaysen expressed confidence in the growth potential in China, citing an ongoing dialogue to reach a resolution. However, without clarifying implications on the business, this presents a risk that could impact future revenue growth.

Exclusive for Stockcircle Pro members

Sign upSign Up
$107.00

Target Price by Analysts

33.3% upsideIllumina Target Price DetailsTarget Price
$49.28

Current Fair Value

38.6% downside

Overvalued by 38.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.00 Billion
Enterprise Value$13.42 Billion
Dividend Yield$0 (0%)
Earnings per Share$-7.69
Beta1.35
Outstanding Shares159,000,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-9.87
PEG4.78
Price to Sales2.97
Price to Book Ratio4.72
Enterprise Value to Revenue3.07
Enterprise Value to EBIT10.56
Enterprise Value to Net Income-11
Total Debt to Enterprise0.19
Debt to Equity0.94

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Illumina Inc

CEO: Francis deSouza